SCHEMBL5131753

SCHEMBL5131753

FC(F)(F)[C](CC1CCCCN1)C(CC1CCCN1)C(F)(F)F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDPS P14324 2/20 0.42
CYP2D6 P10635 3/20 0.41
MEN1 O00255 2/20 0.41
LMNA P02545 2/20 0.41
TP53 P04637 2/20 0.41
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
TSHR P16473 1/20 0.41
MLNR O43193 1/20 0.41
ABCB11 O95342 1/20 0.41
EGFR P00533 1/20 0.41
FYN P06241 1/20 0.41
CHRM2 P08172 1/20 0.41
CHRM4 P08173 1/20 0.41
HTR1A P08908 1/20 0.41
CHRM5 P08912 1/20 0.41
ADRA2A P08913 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
CHRM1 P11229 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5131755 0.77 CYP2D6 (0.52) FDPSCYP2D6MEN1LMNATP53
SCHEMBL5080997 0.77 FDPS (0.49) FDPSCYP2D6MEN1LMNATP53
SCHEMBL5084645 0.75 FDPS (0.42) FDPSCYP2D6MEN1LMNATP53
SCHEMBL24804995 0.66 FDPS (0.53) FDPSCYP2D6MEN1LMNATP53
SCHEMBL29515049 0.66 FDPS (0.53) FDPSCYP2D6MEN1LMNATP53
SCHEMBL11666395 0.66 FDPS (0.53) FDPSCYP2D6MEN1LMNATP53
Trifluoroacetic Acid SCHEMBL30017784 0.66 FDPS (0.38) FDPSMEN1LMNATP53KMT2A
SCHEMBL288736 0.64 FDPS (0.52) FDPSCYP2D6MEN1LMNATP53
SCHEMBL644279 0.64 FDPS (0.52) FDPSCYP2D6MEN1LMNATP53
SCHEMBL5782951 0.64 FDPS (0.52) FDPSCYP2D6MEN1LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8183239-B2 Substituted piperazines and piperidines as modulators of the neuropeptide Y2 receptor JANSSEN PHARMACEUTICA NV (BE) 2012-05-22 US claimed